TORONTO, Jan. 7, 2018 /CNW/ - Due to a clerical error at the TSX, Nuuvera Inc. ("Nuuvera") (TSXV : NUU) was advised by the TSX this morning that it will be open for trading at the market open ‪on Tuesday, January 9, 2018, and not ‪on Monday, January 8, 2018, as previously announced. Nuuvera has been assured by the TSX that the 24-hour delay has been solely caused by the TSX itself and in no way reflects any change in Nuuvera's status as a listed issuer on the TSX Venture Exchange in good standing.

In connection with the trading delay, Ungad Chadda, President, Capital Formation, Toronto Stock Exchange, TSX Venture Exchange, provided the following statement to Nuuvera and its shareholders:

"We are honoured to have Nuuvera join the TSX Venture Exchange and want to assure the public that Nuuvera has been formally approved as a listed company on the TSX Venture Exchange. We also take this opportunity to apologize to Nuuvera and its stakeholders on the delayed first day of trading which was caused by a clerical error. Nuuvera will be available for trading at the open on Tuesday, January 9, 2018, and we look forward to hosting the Nuuvera team to open the market this Wednesday, January 10, 2018 to celebrate their listing."

In response to these events, the President and CEO of Nuuvera, Lorne Abony, issued the following statement:

"We thank the TSX for taking steps to expeditiously resolve this issue, so that Nuuvera can begin trading as quickly as possible. While we are disappointed that we will not begin trading on Monday, as planned, we know that success in our growing industry is all about the long term. Nuuvera has the strategy, team and perspective to create long term success, and to approach this industry in a responsible way. We are eager to provide investors with the opportunity to join us on this mission."

For more information on Nuuvera, please visit: www.nuuvera.com

About Nuuvera

Nuuvera is a global cannabis company founded on Canadian principles, and built with the whole world in mind. Nuuvera is currently working with partners in Germany, Israel and Italy, and is exploring opportunities in several other countries, to develop commercial production and global distribution of medical grade cannabis in legalized markets. Through its subsidiaries, ARA – Avanti Rx Analytics Inc. and Avalon Pharmaceutical Inc., Nuuvera holds a Dealer License (GMP) under the Narcotic Control Regulations and Office of Controlled Substances. Nuuvera is currently in the final stages of the Health Canada review process to become a Licensed Producer of medical marijuana under the ACMPR, and has recently received its "letter to build" approval.

Notice regarding forward-looking statements:

This release includes forward-looking statements regarding Nuuvera and its business. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "is expected", "expects", "scheduled", "intends", "contemplates", "anticipates", "believes", "proposes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Such statements are based on the current expectations of the management of Nuuvera. The forward-looking events and circumstances discussed in this release may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting Nuuvera, including risks regarding the cannabis industry, failure to obtain regulatory approvals, economic factors, the equity markets generally and risks associated with growth and competition. Although Nuuvera has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made Nuuvera undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

The TSX Venture Exchange has in no way passed upon the merits of the transaction and has neither approved nor disapproved the content of this press release.

SOURCE Nuuvera Inc.

For further information: For media inquiries only please contact: Justin Burrows, Venture Communications, [email protected], 1-416-276-7699